MedTech start-up Occuity has received a £343,000 Innovate UK Biomedical Catalyst (BMC) Award to fund the next stage of development of its optical diabetes screening device. The Reading company is developing the AGE reader,  a medical device that will enable non-invasive screening of diabetes in non-clinical settings such as opticians and pharmacies.   Biomedical Catalyst is … Continue reading Occuity wins grant for optical diabetes screening device